Skip to main content
Erschienen in: World Journal of Surgery 8/2009

01.08.2009

Factors Associated with Local Recurrence After Neoadjuvant Chemoradiation with Total Mesorectal Excision for Rectal Cancer

verfasst von: Nam-Kyu Kim, Young-Wan Kim, Byung-Soh Min, Kang-Young Lee, Seung-Kook Sohn, Chang-Hwan Cho

Erschienen in: World Journal of Surgery | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

The purpose of the present study was to investigate risk factors associated with local recurrence in patients with locally advanced rectal cancer who received preoperative chemoradiotherapy in combination with total mesorectal excision (TME).

Methods

Rectal cancer patients who were treated with neoadjuvant chemoradiation with TME were studied. We compared 26 patients who developed local recurrence with 119 recurrence-free patients during the follow-up period.

Results

The median follow-up period was 52 months (range: 14–131 months). Based on the use of univariate and multivariate analyses, circumferential margin involvement (p = 0.02), the presence of lymphovascular or perineural invasion (p = 0.02), and positive nodal disease (p = 0.03) were contributing factors for local recurrence. The local recurrence rate was different between ypN(+) patients and ypN(–) patients with more than 12 nodes retrieved (p = 0.01). There was no difference in local recurrence rates between ypN(+) patients and ypN(–) patients with <12 nodes (p = 0.35) or between ypN(–) patients with <12 nodes or ≥12 nodes (p = 0.18).

Conclusions

Patients with circumferential margin involvement, the presence of lymphovascular or perineural invasion, and positive nodal disease should be regarded as a high-risk group. We also determined that lymph node retrieval (<12 nodes) in patients with node-negative disease was a risk factor for local recurrence.
Literatur
1.
Zurück zum Zitat Swedish Rectal Cancer Trial Group (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer trial. N Engl J Med 336:980–987CrossRef Swedish Rectal Cancer Trial Group (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer trial. N Engl J Med 336:980–987CrossRef
2.
Zurück zum Zitat Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646PubMedCrossRef Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646PubMedCrossRef
3.
Zurück zum Zitat Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740PubMedCrossRef Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740PubMedCrossRef
4.
Zurück zum Zitat Peeters KC, Marijnen CA, Nagtegaal ID et al (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693–701PubMedCrossRef Peeters KC, Marijnen CA, Nagtegaal ID et al (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693–701PubMedCrossRef
5.
Zurück zum Zitat Pilipshen SJ, Heilweil M, Quan SH et al (1984) Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 53:1354–1362PubMedCrossRef Pilipshen SJ, Heilweil M, Quan SH et al (1984) Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 53:1354–1362PubMedCrossRef
6.
Zurück zum Zitat Heslov SF, Frost DB (1988) Extended resection for primary colorectal carcinoma involving adjacent organs or structures. Cancer 62:1637–1640PubMedCrossRef Heslov SF, Frost DB (1988) Extended resection for primary colorectal carcinoma involving adjacent organs or structures. Cancer 62:1637–1640PubMedCrossRef
7.
Zurück zum Zitat Sagar PM, Pemberton JH (1996) Surgical management of locally recurrent rectal cancer. Br J Surg 83:293–304PubMedCrossRef Sagar PM, Pemberton JH (1996) Surgical management of locally recurrent rectal cancer. Br J Surg 83:293–304PubMedCrossRef
8.
Zurück zum Zitat Green FL, Page DL, Fleming IF et al (eds) (2002) AJCC (American Joint Committee on Cancer) Cancer Staging Manual, 6th edn. Springer-Verlag, New York, pp 127–138 Green FL, Page DL, Fleming IF et al (eds) (2002) AJCC (American Joint Committee on Cancer) Cancer Staging Manual, 6th edn. Springer-Verlag, New York, pp 127–138
9.
Zurück zum Zitat Hammond MEH, Fitzgibbons PL, Compton CC et al (2000) College of American pathologists conference XXXV: solid tumor prognostic factors—which, how, and so what? Arch Pathol Lab Med 124:958–965PubMed Hammond MEH, Fitzgibbons PL, Compton CC et al (2000) College of American pathologists conference XXXV: solid tumor prognostic factors—which, how, and so what? Arch Pathol Lab Med 124:958–965PubMed
10.
Zurück zum Zitat Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479–1482PubMedCrossRef Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479–1482PubMedCrossRef
11.
Zurück zum Zitat Law WL, Chu KW (2004) Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg 240:260–268PubMedCrossRef Law WL, Chu KW (2004) Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg 240:260–268PubMedCrossRef
12.
Zurück zum Zitat Baik SH, Kim NK, Lee YC et al (2007) Prognostic significance of circumferential resection margin following total mesorectal excision and adjuvant chemoradiotherapy in patients with rectal cancer. Ann Surg Oncol 14:462–469PubMedCrossRef Baik SH, Kim NK, Lee YC et al (2007) Prognostic significance of circumferential resection margin following total mesorectal excision and adjuvant chemoradiotherapy in patients with rectal cancer. Ann Surg Oncol 14:462–469PubMedCrossRef
13.
Zurück zum Zitat Minsky BD, Cohen AM, Enker WE et al (1997) Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys 37:289–295PubMed Minsky BD, Cohen AM, Enker WE et al (1997) Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys 37:289–295PubMed
14.
Zurück zum Zitat Ahmad NR, Nagle D (1997) Long-term results of preoperative radiation therapy alone for stage T3 and T4 rectal cancer. Br J Surg 84:1445–1448PubMedCrossRef Ahmad NR, Nagle D (1997) Long-term results of preoperative radiation therapy alone for stage T3 and T4 rectal cancer. Br J Surg 84:1445–1448PubMedCrossRef
15.
Zurück zum Zitat Mohiuddin M, Regine WF, John WJ et al (2000) Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological compete response. Int J Radiat Oncol Biol Phys 46:883–888PubMed Mohiuddin M, Regine WF, John WJ et al (2000) Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological compete response. Int J Radiat Oncol Biol Phys 46:883–888PubMed
16.
Zurück zum Zitat Kim NK, Baik SH, Min BS et al (2007) A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation. Int J Radiat Oncol Biol Phys 67:204–210PubMed Kim NK, Baik SH, Min BS et al (2007) A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation. Int J Radiat Oncol Biol Phys 67:204–210PubMed
17.
Zurück zum Zitat Mawdsley S, Glynne-Jones R, Grainger J et al (2005) Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3–T4 rectal cancer predict for 3-year disease-free survival? Int J Radiat Oncol Biol Phys 63:745–752PubMed Mawdsley S, Glynne-Jones R, Grainger J et al (2005) Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3–T4 rectal cancer predict for 3-year disease-free survival? Int J Radiat Oncol Biol Phys 63:745–752PubMed
18.
Zurück zum Zitat Moore HG, Riedel E, Minsky BD et al (2003) Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 10:80–85PubMedCrossRef Moore HG, Riedel E, Minsky BD et al (2003) Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 10:80–85PubMedCrossRef
19.
Zurück zum Zitat Quirke P, Durdey P, Dixon MF et al (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumor spread and surgical excision. Lancet 2:996–999PubMedCrossRef Quirke P, Durdey P, Dixon MF et al (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumor spread and surgical excision. Lancet 2:996–999PubMedCrossRef
20.
Zurück zum Zitat Nagtegaal ID, Marijnen CA, Kranenbarg EK et al (2002) Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 26:350–357PubMedCrossRef Nagtegaal ID, Marijnen CA, Kranenbarg EK et al (2002) Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 26:350–357PubMedCrossRef
21.
Zurück zum Zitat Gosens MJEM, Klaassen RA, Tan-Go I et al (2007) Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma. Clin Cancer Res 13:6617–6623PubMedCrossRef Gosens MJEM, Klaassen RA, Tan-Go I et al (2007) Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma. Clin Cancer Res 13:6617–6623PubMedCrossRef
22.
Zurück zum Zitat Guillem JG, Chessin DB, Cohen AM et al (2005) Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 241:829–836PubMedCrossRef Guillem JG, Chessin DB, Cohen AM et al (2005) Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 241:829–836PubMedCrossRef
23.
Zurück zum Zitat Ruo L, Tickoo S, Klimstra DS et al (2002) Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 236:75–81PubMedCrossRef Ruo L, Tickoo S, Klimstra DS et al (2002) Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 236:75–81PubMedCrossRef
24.
Zurück zum Zitat Kim NK, Baik SH, Seong JS et al (2006) Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: impact of postirradiated pathologic downstaging on local recurrence and survival. Ann Surg 244:1024–1030PubMedCrossRef Kim NK, Baik SH, Seong JS et al (2006) Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: impact of postirradiated pathologic downstaging on local recurrence and survival. Ann Surg 244:1024–1030PubMedCrossRef
25.
Zurück zum Zitat Onaitis MW, Noone RB, Hartwig M et al (2001) Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann Surg 233:778–785PubMedCrossRef Onaitis MW, Noone RB, Hartwig M et al (2001) Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann Surg 233:778–785PubMedCrossRef
26.
Zurück zum Zitat Kuo LJ, Liu MC, Jian JJ et al (2007) Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol 14:2766–2772PubMedCrossRef Kuo LJ, Liu MC, Jian JJ et al (2007) Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol 14:2766–2772PubMedCrossRef
27.
Zurück zum Zitat Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P et al (2003) A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 46:298–304PubMedCrossRef Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P et al (2003) A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 46:298–304PubMedCrossRef
28.
Zurück zum Zitat Baxter NN, Morris AM, Rothenberger DA et al (2005) Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys 61:426–431PubMed Baxter NN, Morris AM, Rothenberger DA et al (2005) Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys 61:426–431PubMed
29.
Zurück zum Zitat Wong JH, Severino R, Honnebier MB et al (1999) Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 17:2896–2900PubMed Wong JH, Severino R, Honnebier MB et al (1999) Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 17:2896–2900PubMed
30.
Zurück zum Zitat Sarli L, Bader G, Iusco D et al (2005) Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer 41:272–279PubMedCrossRef Sarli L, Bader G, Iusco D et al (2005) Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer 41:272–279PubMedCrossRef
31.
Zurück zum Zitat Baxter NN, Virnig DJ, Rothenberger DA et al (2005) Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 97:219–225PubMedCrossRef Baxter NN, Virnig DJ, Rothenberger DA et al (2005) Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 97:219–225PubMedCrossRef
32.
Zurück zum Zitat Goldstein NS (2002) Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 26:179–189PubMedCrossRef Goldstein NS (2002) Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 26:179–189PubMedCrossRef
33.
Zurück zum Zitat Luna-Perez P, Rodriguez-Ramirez S, Alvarado I et al (2003) Prognostic significance of retrieved lymph nodes per specimen in resected rectal adenocarcinoma after preoperative chemoradiation therapy. Arch Med Res 34:281–286PubMedCrossRef Luna-Perez P, Rodriguez-Ramirez S, Alvarado I et al (2003) Prognostic significance of retrieved lymph nodes per specimen in resected rectal adenocarcinoma after preoperative chemoradiation therapy. Arch Med Res 34:281–286PubMedCrossRef
Metadaten
Titel
Factors Associated with Local Recurrence After Neoadjuvant Chemoradiation with Total Mesorectal Excision for Rectal Cancer
verfasst von
Nam-Kyu Kim
Young-Wan Kim
Byung-Soh Min
Kang-Young Lee
Seung-Kook Sohn
Chang-Hwan Cho
Publikationsdatum
01.08.2009
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 8/2009
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-009-0077-4

Weitere Artikel der Ausgabe 8/2009

World Journal of Surgery 8/2009 Zur Ausgabe

Letter

Reply

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.